Vaccine Efficacy in Clinical Trials

Race and ethnic group categories shown are White (non- Hispanic) and communities of color (all others, excluding those whose race and ethnicity were both reported as un- known, were not reported, or were both missing at screening). Data for communities of color were pooled owing to limited numbers of participants in each racial or ethnic group, to ensure that the subpopulations would be large enough for meaningful analyses.

Sources: Baden, L.R., H.M. El Sahly, B. Essink, et al. (2021). Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med, 384:403-16. DOI: 10.1056/NEJMoa2035389; Choi M.J., C.M. Cossaboom, A.N. Whitesell, et al. (2021). Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep, 70 (No. RR-1):1–12. DOI: http://dx.doi.org/10.15585/mmwr.rr7001a1; Harper, D.M. and L.R. DeMars (2017). HPV vaccines – A review of the first decade. Gynecologic Oncology 2017; 146: 196-204. DOI: https://doi.org/10.1016/j.ygyno.2017.04.004; Maltz, F., & Fidler, B. (2019). Shingrix: A New Herpes Zoster Vaccine. P & T : a peer-reviewed journal for formulary management, 44(7), 406–433; Pollack, F.P., S.J. Thomas, N. Kitchin, et al. (2020). Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med, 383:2603-2615. DOI: 10.1056/NEJMoa2034577; Sadoff, J.C., G. Gray, A. Vandebosch, et al. (2021). Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med, 384:2187-2201. DOI: 10.1056/NEJMoa2101544